SureTrader Advertisement PRTC
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Will Truvada, as a prophylactic, have applications in

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
oc631 Member Profile
Member Level 
Followed By 14
Posts 1,662
Boards Moderated 0
Alias Born 08/12/07
160x600 placeholder
Asr Nederland Ipo Could Value Insurer At $3 Billion
The Dutch state is selling a stake of up to 40% in ASR Nederland via an initial public offering that could value the insurer at more than $3 billion.
More Top Equities Stories Of The Day
When Bigger Isn't Better: Banks Retreat From Global Ambitions
Correction to Microsoft Smartphone Article on Wednesday
Facebook and Microsoft To Build Fiber Optic Cable Across Atlantic
Indian Ministries Divide on Apple's Retail Vision
ADRs End Mostly Lower; Alibaba, Baidu Trade Actively
Bank of America Relaunches Sale of Credit-Card Issuer MBNA
Valeant Rejected Joint Takeover Approach From Takeda, TPG
Thermo Fisher Scientific to Buy FEI for $4.2 Billion
oc631 Member Level  Saturday, 05/12/12 03:34:19 PM
Re: bladerunner1717 post# 141855
Post # of 201672 
Quote:
Will Truvada, as a prophylactic, have applications in the Third World, especially Africa? Wouldn't the Gates Foundation and WHO want to get involved with this drug?





Truvada prophylaxis testing was first done using prostitutes in Africa. Outside of cost there would be problems with user compliance in third world countries.

Prophylaxis seems like a good idea when demonstrated in a controlled environment, not in the third world. User compliance will be difficult even here in the U.S.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist